Published in J Infect Dis on May 01, 1992
Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis (2004) 1.18
Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults. BMC Infect Dis (2007) 1.18
Performance of Interleukin-6 and Interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk. BMC Infect Dis (2008) 0.93
The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia. Support Care Cancer (2010) 0.91
Cytokines in nasopharyngeal secretions; evidence for defective IL-1 beta production in children with recurrent episodes of acute otitis media. Clin Exp Immunol (1994) 0.88
Procalcitonin and C-reactive protein in the diagnosis and prediction of spontaneous bacterial peritonitis associated with chronic severe hepatitis B. Ann Lab Med (2013) 0.88
Endothelial cells are main producers of interleukin 8 through Toll-like receptor 2 and 4 signaling during bacterial infection in leukopenic cancer patients. Clin Diagn Lab Immunol (2003) 0.85
Predicting infectious complications in neutropenic children and young people with cancer (IPD protocol). Syst Rev (2012) 0.80
Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein. Support Care Cancer (2013) 0.80
A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains. Proc Natl Acad Sci U S A (1998) 4.75
Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg (1995) 3.62
Childhood cancer and ethnic group in Britain: a United Kingdom children's Cancer Study Group (UKCCSG) study. Br J Cancer (1991) 2.33
Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis. Br J Radiol (1997) 2.06
Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann Rheum Dis (1990) 2.04
Cytosine arabinoside in the treatment of acute myeloblastic leukaemia. Lancet (1971) 1.94
Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group. J Clin Oncol (1993) 1.93
Dermatologic consultations in the hospital setting. Arch Dermatol (1994) 1.91
Characterization of repetitive DNA in the Mycoplasma genitalium genome: possible role in the generation of antigenic variation. Proc Natl Acad Sci U S A (1995) 1.90
Transposition of the gene encoding a TEM-12 extended-spectrum beta-lactamase. Antimicrob Agents Chemother (1992) 1.84
Preliminary results of a physiologically based treatment of amblyopia. Br J Ophthalmol (1978) 1.84
Excess benign melanocytic naevi after chemotherapy for malignancy in childhood. BMJ (1989) 1.73
Reduction in circulating levels of CD4-positive lymphocytes in acute pancreatitis: relationship to endotoxin, interleukin 6 and disease severity. Br J Surg (1993) 1.73
Epidemiology of childhood brain tumours in Yorkshire, UK, 1974-95: geographical distribution and changing patterns of occurrence. Br J Cancer (1998) 1.70
Government investment in health care. Sci Am (1971) 1.64
Incidence and predictors of axillary metastasis in T1 carcinoma of the breast. J Am Coll Surg (1996) 1.63
Liquid crystal thermography and C reactive protein in the detection of deep venous thrombosis. BMJ (1989) 1.60
Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward. J Antimicrob Chemother (1995) 1.57
Interdisciplinary health professional education: a historical review. Adv Health Sci Educ Theory Pract (2001) 1.50
Serum amyloid-A protein concentration in rheumatoid arthritis and its role in monitoring disease activity. Ann Rheum Dis (1983) 1.39
Trilostane as cause of Addisonian crisis. Lancet (1981) 1.38
Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Int J Cancer (1994) 1.37
Glandular fever-like syndrome, pulmonary eosinophilia and asthma associated with carbamazepine. Postgrad Med J (1982) 1.32
Growth and skeletal maturation in congenital adrenal hyperplasia. Review of 20 cases. Arch Dis Child (1974) 1.32
Facilitating factors for, barriers to, and outcomes of interdisciplinary education projects in the health sciences. J Allied Health (2000) 1.30
An evaluation of the Hyland laser nephelometer PDQ system for the measurement of immunoglobulins. Ann Clin Biochem (1978) 1.28
Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials. Ann Oncol (2011) 1.28
The treatment of gout with azapropazone: clinical and experimental studies. Eur J Rheumatol Inflamm (1981) 1.26
Acute phase response of serum amyloid A protein and C reactive protein to the common cold and influenza. J Clin Pathol (1985) 1.25
Serum amyloid A protein compared with C-reactive protein, alpha 1-antichymotrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease. Eur J Clin Invest (1987) 1.24
Diarrhoea due to Cryptosporidium in acute lymphoblastic leukemia. Arch Dis Child (1985) 1.22
The value of complement assays in clinical chemistry. Clin Chem (1978) 1.18
The value of acute phase protein measurements in clinical practice. Ann Clin Biochem (1992) 1.18
Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials. Br J Haematol (1995) 1.17
B cell function in acquired "common-variable" hypogammaglobulinemia: proliferative responses to lymphokines. Clin Immunol Immunopathol (1989) 1.16
Conduct of phase I trials in children with cancer. J Clin Oncol (1998) 1.16
Clinical applications of immunofixation: detection and quantitation of complement activation. J Clin Pathol (1980) 1.15
Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia. Br J Haematol (1997) 1.14
The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties. Leukemia (1998) 1.10
Mitral regurgitation after anthracycline treatment for childhood malignancy. Heart (2001) 1.10
Preparation of a calibration material for specific protein assay (SPS-01). Ann Clin Biochem (1984) 1.08
Science and health care--the political problem. N Engl J Med (1969) 1.07
Cytokines in disease. Clin Chem (1990) 1.07
The laboratory investigation of paraproteinaemia. Ann Clin Biochem (1987) 1.06
MutS binding protects heteroduplex DNA from exonuclease digestion in vitro: a simple method for detecting mutations. Nucleic Acids Res (1994) 1.05
Measurement of plasma concentrations of polymorphonuclear elastase-alpha 1 proteinase inhibitor (elastase-alpha 1 antitrypsin) in patients with rheumatoid arthritis: interference by rheumatoid factor. Ann Rheum Dis (1990) 1.05
Activation of the alternative pathway of complement by monosodium urate monohydrate crystals and other inflammatory particles. Ann Rheum Dis (1983) 1.05
Enteropathy complicating maintenance therapy in acute lymphoblastic leukaemia. Arch Dis Child (1982) 1.05
A combined cytogenetic and molecular approach to diagnosis in a case of desmoplastic small round cell tumor with a complex translocation (11;22;21). Cancer Genet Cytogenet (1999) 1.05
Ethnic group and survival from childhood cancer: report from the UK Children's Cancer Study Group. Br J Cancer (2000) 1.04
Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation. J Clin Oncol (1992) 1.04
Absence of prostaglandin stimulated increase in acute phase proteins in systemic sclerosis. Lancet (1980) 1.04
A reappraisal of routine marrow examination therapy of acute lymphoblasticv leukaemia. Arch Dis Child (1981) 1.04
Tests for detecting and monitoring the acute phase response. Arch Dis Child (1988) 1.04
Familial microcephaly with normal intelligence in a patient with acute lymphoblastic leukemia. Cancer (1992) 1.03
Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial. Eur J Cancer (2010) 1.02
Interleukin-6 and ACTH act synergistically to stimulate the release of corticosterone from adrenal gland cells. Clin Exp Immunol (1990) 1.02
A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma. Health Technol Assess (2003) 1.01
MRC UKALL X. The UK protocol for childhood ALL: 1985-1990. The Medical Research Council Working Party on Childhood Leukaemia. Leukemia (1992) 1.01
Centromeric instability of chromosomes 1 and 16 with variable immune deficiency: a new syndrome. Clin Genet (1985) 1.00
Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia. Br J Haematol (1997) 1.00
A protein of squamous keratinising epithelium from odontogenic keratocyst fluid. Virchows Arch A Pathol Anat Histopathol (1986) 0.99
Is coagulase-negative staphylococcal bacteraemia in neonates a consequence of mechanical ventilation? J Hosp Infect (1985) 0.99
Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group. Br J Cancer (1998) 0.99
Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia. Leukemia (1994) 0.99
12q13 abnormality in rhabdomyosarcoma. A nonrandom occurrence? Cancer Genet Cytogenet (1992) 0.98
EWS-FLI1 fusion transcripts identified in patients with typical neuroblastoma. Eur J Cancer (1997) 0.98
Reflex responses of sympathetic preganglionic neurones initiated by different cardiovascular receptors in spinal animals. Brain Res (1974) 0.97
Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Eur J Cancer (1995) 0.97
Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year. J Clin Oncol (2001) 0.97
A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family. Eur J Cancer (2003) 0.97
External quality assessment of total urinary protein estimation in the United Kingdom. Ann Clin Biochem (1991) 0.97
A phase II study of interferon-alpha, interleukin-2 and 5-fluorouracil in advanced renal carcinoma: clinical data and laboratory evidence of protease activation. Br J Urol (1996) 0.96
Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI). Br J Haematol (2001) 0.96
Possible placental origin of ACTH in normal human pregnancy. Nature (1975) 0.96
Survival from childhood cancer in Yorkshire, U.K.: effect of ethnicity and socio-economic status. Eur J Cancer (1999) 0.96
Interleukin 2 and diacylglycerol stimulate phosphorylation of 40 S ribosomal S6 protein. Correlation with increased protein synthesis and S6 kinase activation. J Biol Chem (1987) 0.95
Minimal residual disease at the time of peripheral blood stem cell harvest in patients with advanced neuroblastoma. Med Pediatr Oncol (2001) 0.95
Serum copper and caeruloplasmin in ankylosing spondylitis, systemic sclerosis, and morphea. Ann Rheum Dis (1975) 0.95
Effects of anti-proliferative cyclic AMP on interleukin 2-stimulated gene expression. J Immunol (1987) 0.95
The acute phase protein response in patients receiving subcutaneous IL-6. Clin Exp Immunol (1995) 0.95
Immunonephelometric and immunoturbidimetric assays for proteins. Crit Rev Clin Lab Sci (1983) 0.95
Expression of interleukin-6 by intestinal enterocytes. J Clin Pathol (1993) 0.95
Thalidomide treatment for chronic graft-versus-host disease. Br J Haematol (1991) 0.95
Serum interleukin-8 in inflammatory bowel disease. J Gastroenterol Hepatol (1994) 0.95
Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X. Arch Dis Child (1996) 0.95
Cancer incidence among the south Asian and non-south Asian population under 30 years of age in Yorkshire, UK. Br J Cancer (2010) 0.95
Cytomorphology of childhood lymphoblastic leukaemia: a prospective study of 2000 patients. United Kingdom Medical Research Council's Working Party on Childhood Leukaemia. Br J Haematol (1992) 0.94
Stimulation of specific GTP binding and hydrolysis activities in lymphocyte membrane by interleukin-2. Nature (1987) 0.94
Immunochemical assays for immunoglobulins. Ann Clin Biochem (1984) 0.93
Biochemical and molecular events associated with interleukin 2 regulation of lymphocyte proliferation. Immunol Rev (1986) 0.93